From the Brain Tumor Center and Department of Neuro-Oncology.
J Biol Chem. 2013 Nov 1;288(44):31488-95. doi: 10.1074/jbc.M113.499020. Epub 2013 Sep 17.
Activated EGF receptor (EGFR) signaling plays an instrumental role in glioblastoma (GBM) progression. However, how EGFR activation regulates the tumor microenvironment to promote GBM cell invasion remains to be clarified. Here, we demonstrate that the levels of EGFR activation in tumor cells correlated with the levels of macrophage infiltration in human GBM specimens. This was supported by our observation that EGFR activation enhanced the interaction between macrophages and GBM cells. In addition, EGF treatment induced up-regulation of vascular cell adhesion molecule-1 (VCAM-1) expression in a PKCε- and NF-κB-dependent manner. Depletion of VCAM-1 interrupted the binding of macrophages to GBM cells and inhibited EGF-induced and macrophage-promoted GBM cell invasion. These results demonstrate an instrumental role for EGF-induced up-regulation of VCAM-1 expression in EGFR activation-promoted macrophage-tumor cell interaction and tumor cell invasion and indicate that VCAM-1 is a potential molecular target for improving cancer therapy.
激活的表皮生长因子受体(EGFR)信号在胶质母细胞瘤(GBM)的进展中起着重要作用。然而,EGFR 激活如何调节肿瘤微环境以促进 GBM 细胞侵袭仍有待阐明。在这里,我们证明肿瘤细胞中 EGFR 激活的水平与人类 GBM 标本中巨噬细胞浸润的水平相关。这一点得到了我们的观察结果的支持,即 EGFR 激活增强了巨噬细胞与 GBM 细胞之间的相互作用。此外,EGF 处理以 PKCε和 NF-κB 依赖的方式诱导血管细胞粘附分子-1(VCAM-1)的表达上调。VCAM-1 的耗竭中断了巨噬细胞与 GBM 细胞的结合,并抑制了 EGF 诱导和巨噬细胞促进的 GBM 细胞侵袭。这些结果表明,EGF 诱导的 VCAM-1 表达上调在 EGFR 激活促进的巨噬细胞-肿瘤细胞相互作用和肿瘤细胞侵袭中起着重要作用,并表明 VCAM-1 是改善癌症治疗的潜在分子靶标。